Sch 1 - RII plc

RNS Number:8440H
AIM
27 January 2005


         ANNOUNCEMENT TO BE MADE BY AIM APPLICANT AT LEAST 10 BUSINESS 
                         DAYS PRIOR TO ADMISSION

ALL APPLICANTS MUST COMPLETE THE FOLLOWING:

COMPANY NAME:
RII plc (to be renamed Mister Pharmaceuticals)

COMPANY ADDRESS:
56 Queen Anne Street, London

COMPANY POSTCODE:
W1G 8LA

COUNTRY OF INCORPORATION:
England

COMPANY BUSINESS:
Biotechnology

DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, 
nominal value and issue price):
1,553,698 in Ordinary Shares of 0.1p each

CAPITAL TO BE RAISED ON ADMISSION:
#3,000,000

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:
Robert Stubbs - Chairman
Clive McGuire - Non Executive Director
Dr Paul Sharpe - Proposed Chairman and Chief  Executive Officer
Robert Aubrey - Proposed Chief Operating Officer
Dr Peter Blower - Proposed Executive Director

PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A
PERCENTAGE OF THE ISSUED SHARE CAPITAL STATING WHETHER BEFORE OR AFTER
ADMISSION:

Before admission the following people are directly interested in 3% or more of 
the issued shares in the Company;

                                                                            % of
                                                                    Issued Share
Shareholder                                      No. of Shares           Capital

Pershing Keen Nominees Limited HHCLT Acct        28,572,231                 17.7
P Bullen a/c M Edwards
Pershing Keen Nominees Limited PSL981 Acct       11,675,673                  7.2
Langham Investment Corporation Limited           10,000,000                  6.2
B Salmanpour
Rock (Nominees) Limited 1802730 Account           8,695,652                  5.4
Clive Roberts
W B Nominees Limited                              5,872,101                  3.6
Maurice Gould                                     5,797,101                  3.6
Philip John Rowen                                 5,797,101                  3.6
Ian Weaver                                        5,797,101                  3.6
Shuman Brothers Inc                               4,881,754                  3.0


NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 
2, PARAGRAPH (G) OF THE AIM RULES.
N/A

ANTICIPATED ACCOUNTING REFERENCE DATE:
31 March

EXPECTED ADMISSION DATE:
Friday 25 February 2005

NAME AND ADDRESS OF NOMINATED ADVISER
Insinger de Beaufort
44 Worship Street
London
EC2A 2JT

NAME AND ADDRESS OF BROKER
Insinger de Beaufort
44 Worship Street
London
EC2A 2JT

DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE
AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE
APPLICANT AND THE ADMISSION OF ITS SECURITIES
56 Queen Anne Street, London W1G 8LA

DATE OF NOTIFICATION/  STATEMENT
27 January 2005

NEW/ UPDATE (see note):  NEW

LISTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING:

DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE
OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY
N/A

A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE
APPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FOR
WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED OR AN APPROPRIATE NEGATIVE
STATEMENT
N/A

A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT
ITS WORKING CAPITAL WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE
DATE OF ITS ADMISSION
N/A


DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES.
N/A




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

PAAPUUWWGUPAGQQ